
Avient Corp (AVNT) Stock Forecast & Price Target
Avient Corp (AVNT) Analyst Ratings
Bulls say
Avient Corp has experienced a notable organic sales increase of 5%, indicating solid performance across its segments. The healthcare sales segment has shown remarkable resilience, achieving double-digit growth for six consecutive quarters and a significant year-over-year increase of 14% in the first half of 2025. Additionally, four out of nine end markets, which collectively account for 40% of Avient's sales, are expanding, contributing to an overall organic sales growth of approximately 2% for 2025.
Bears say
Avient Corp has registered a decline in organic sales, reporting a drop of approximately 2% in the first quarter of 2024, despite experiencing a recovery with 5% year-over-year growth in the subsequent quarters. Additionally, the company faces weakening demand in the chemicals sector, with forecasts indicating potential downside risks to volumes in the second half of 2025. While a declining dollar may provide a temporary benefit, the overall negative trends in sales and demand raise concerns about the company's financial stability moving forward.
This aggregate rating is based on analysts' research of Avient Corp and is not a guaranteed prediction by Public.com or investment advice.
Avient Corp (AVNT) Analyst Forecast & Price Prediction
Start investing in Avient Corp (AVNT)
Order type
Buy in
Order amount
Est. shares
0 shares